Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.
Status: Publicly traded
Direct answer
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. is publicly traded on HKSE under the ticker 2566.HK.
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, manufacturing, and commercialization of biopharmaceutical products and medical devices in Mainland China and internationally. The company offers Guyoudao, a bone repair material; Jilifen, a human granulocyte colony stimulating factor injection; Jijufen, a human interleukin-11 injection; Jiouting,...
Can you invest in Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.?
Yes. Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. trades publicly on HKSE as 2566.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.
Detailed equity research is provided by MarketSnap.